Fungal infection
Conditions
Brief summary
Postoperative complications measured by Clavien Dindo III-V classification score
Detailed description
Days Alive and Out of Hospital measured within the 90th postoperative day, Time to gastrointestinal function (first bowel movement) postoperatively, Reduction in percentage of patients who require placement of nasogastric tube postoperatively, Quality of Life measured by questionnaires (EORTC QLQ-C30 and QLQ-BLM30) at day 0 and day 90, Length of stay for index admission, Re-admission within 30 and 90 days, Microbiome resistance development in the urinary tract, Urinary tract infections requiring treatment
Interventions
DRUGFluconazole Kabi 2mg/ml solution for infusion
Sponsors
Rigshospitalet
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative complications measured by Clavien Dindo III-V classification score | — |
Secondary
| Measure | Time frame |
|---|---|
| Days Alive and Out of Hospital measured within the 90th postoperative day, Time to gastrointestinal function (first bowel movement) postoperatively, Reduction in percentage of patients who require placement of nasogastric tube postoperatively, Quality of Life measured by questionnaires (EORTC QLQ-C30 and QLQ-BLM30) at day 0 and day 90, Length of stay for index admission, Re-admission within 30 and 90 days, Microbiome resistance development in the urinary tract, Urinary tract infections requiring treatment | — |
Countries
Denmark
Outcome results
None listed